Seeing Is Believing
Kindred Biosciences's activity chart (see below) currently has 37 price targets and 34 ratings on display.
Analysts average stock forecasts to be materialized ratio is 46.35% with an average time for these price targets to be met of 177.62 days.
Most recent stock forecast was given by BEN HAYNOR from ALLIANCE GLOBAL PARTNERS on 23-Aug-2021. First documented stock forecast 15-Nov-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 03-Aug-2017
$15.25
Buy Since 17-Nov-2017
$9
Buy Since 24-Jul-2018
$9.25
Buy Since 23-May-2019
$9
$-0.25 (-2.70%)
$13
What is KIN (Kindred Biosciences) average time for price targets to be met?
Which analyst has the current highest performing score on KIN (Kindred Biosciences) with a proven track record?
Which analyst has the most public recommendations on KIN (Kindred Biosciences)?
Which analyst is the currently most bullish on KIN (Kindred Biosciences)?
Which analyst is the currently most reserved on KIN (Kindred Biosciences)?